Low serum alkaline phosphatase activity and pathologic fracture: Case report and brief review of hypophosphatasia diagnosed in adulthood

Endocrine Practice

Volumn 12, Issue 6, 2006, Pages 676-681

  Khandwala, Hasnain M ^a   Mumm, Steven ^b,c   Whyte, Michael P ^b,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE;

BLOOD; CASE REPORT; FEMALE; FEMUR FRACTURE; GENETICS; HUMAN; HYPOPHOSPHATASIA; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGIC FRACTURE; REVIEW;

ALKALINE PHOSPHATASE; DNA MUTATIONAL ANALYSIS; FEMALE; FEMORAL FRACTURES; FRACTURES, SPONTANEOUS; HUMANS; HYPOPHOSPHATASIA; MIDDLE AGED; MUTATION, MISSENSE;

EID: 33847748635     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.6.676     Document Type: Article

References (33)

1. Whyte MP. Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill, 2001: 5313-5329.
2. Whyte MP. Hypophosphatasia: nature's window on alkaline phosphatase function in man. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. 2nd ed. San Diego, CA: Academic Press, 2002: 1229-1248.
3. Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli L. Adult hypophosphatasia: clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore). 1979;58:329-347.
4. Weinstein RS, Whyte MP. Heterogeneity of adult hypophosphatasia: report of severe and mild cases. Arch Intern Med. 1981;141:727-731.
5. Whyte MP, Murphy WA, Fallon MD. Adult hypophosphatasia with chondrocalcinosis and arthropathy: variable penetrance of hypophosphatasemia in a large Oklahoma kindred. Am J Med. 1982;72:631-641.
6. Whyte MP, Mahuren JD, Fedde KN, Cole FS, McCabe ER, Coburn SP. Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxa1-5′-phosphate; evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest. 1988;81:1234-1239.
7. Mumm S, Jones J, Finnegan P, Henthorn PS, Podgornik MN, Whyte MP. Denaturing gradient gel electrophoresis analysis of the tissue nonspecific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab. 2002;75:143-153.
8. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet. 2001;109:121-124.
9. The Tissue Nonspecific Alkaline Phosphatase Gene Mutations Database. Available at: www.sesep.uvsq.fr/database-hypo/hypophosphatasia.html. Accessed for verification March 11, 2006.
10. Taillandier A, Lia-Baldini AS, Mouchard M, et al. Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia. Hum Mutat. 2001;18:83-84.
11. Rathbun JC. Hypophosphatasia: a new developmental anomaly. Am J Dis Child. 1948;75:822-831.
12. Barcia JP, Strife CF, Langman CB. Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J Pediatr. 1997;130:825-828.
13. Greenberg CR, Taylor CL, Haworth JC, et al. A homoallelic Gly317-to-Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian Mennonites. Genomics. 1993;17:215-217.
14. Whyte MP, Essmyer K, Geimer M, Mumm S. Homozygosity for TNSALP mutation 1348C>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr. 2006;148:753-758.
15. Whyte MP. Rickets and osteomalacia (acquired and heritable forms). In: Wass JAH, Shalet SM, eds. The Oxford Textbook of Endocrinology and Diabetes. Oxford, UK: Oxford University Press, 2002: 697-715.
16. Cheung CP, Suhadolnik RJ. Analysis of inorganic pyrophosphate at the picomole level. Ann Biochem. 1977;83:61-63.
17. Fallon MD, Teitelbaum SL, Weinstein RS, Goldfischer S, Brown DM, Whyte MP. Hypophosphatasia: clinico-pathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore). 1984;63:12-24.
18. van den Bos T, Handoko G, Niehof A, et al. Cementum and dentin in hypophosphatasia. J Dent Res. 2005;84:1021-1025.
19. GeneTests. Available at: http://genetests.org/. Accessed for verification March 11, 2006.
20. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem. 2001;276:31171-31178.
21. Bossi M, Hoylaerts MF, Millan JL. Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. J Biol Chem. 1993;268:25409-25416.
22. Taillandier A, Sallinen SL, Brun-Heath I, De Mazancourt P, Serre JL, Mornet E. Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene. J Clin Endocrinol Metab. 2005;90:2436-2439.
23. Coe JD, Murphy WA, Whyte MP. Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am. 1986;68:981-990.
24. Whyte MP, Seino Y. Circulating vitamin D metabolite levels in hypophosphatasia. J Clin Endocrinol Metab. 1982;55:178-180.
25. Heinonen JK. Biological Role of Inorganic Pyrophosphate. Norwell, MA: Kluwer Academic Publishers, 2001.
26. Thomas T, Lafage MH, Alexandre C. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis. J Rheumatol. 1995;22:2183-2185.
27. Robison R. The possible significance of hexosephosphoric esters in ossification. Biochem J. 1923;17:286-293.
28. Whyte MP, McAlister WH, Patton LS, et al. Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J Pediatr. 1984;105:926-933.
29. Whyte MP, Kurtzberg J, McAlister WH, et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res. 2003;18:624-636.
30. Cahill R, Perlman S, Mumm S, McAlister WH, Whyte MP. Successful transplantation of infantile hypophosphatasia using bone fragments and cultured osteoblasts [abstract]. J Bone Miner Res. 2005;20(Suppl 1):S117.
31. Deal CL, Whyte MP. Adult hypophosphatasia treated with teriparatide [abstract]. J Bone Miner Res. 2005;20(Suppl 1):S100.
32. Wenkert D, Podgornik MN, Coburn SP, et al. Dietary phosphate restriction therapy for hypophosphatasia: preliminary observations [abstract]. J Bone Miner Res. 2002;17:S384.
33. Coburn SP, Mahuren JD, Jain M, Zubovic Y, Wortsman J. Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. J Clin Endocrinol Metab. 1998;83:3951-3957.